Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients
Alvin F. Wells(Dermatology Research Center), Jacob Aelion(Middle Tennessee Research Institute), Nikolay Delev(Bristol-Myers Squibb (Sweden)), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Alan Kivitz(Altoona Center for Clinical Research), Maria Paris(Amgen (United States)), B. Guérette, Lichen Teng(Harbin Medical University), Paul Bird(UNSW Sydney)
Cited by 12
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668